1099323

Fresenius Kabi USA, LLC — FEI 3001833549

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Island, NY (United States)